Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
出版年份 2018 全文链接
标题
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
作者
关键词
Type 2 diabetes, Metformin, Atorvastatin, Simvastatin, Combination therapy, Dyslipidemia, Glucose metabolism, Lipid metabolism
出版物
Cardiovascular Diabetology
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-06-30
DOI
10.1186/s12933-018-0738-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats
- (2018) Tariq Jamal Khan et al. Scientific Reports
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis
- (2017) Shaohua Wang et al. Scientific Reports
- Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
- (2017) Jose A. Caparrós-Martín et al. Microbiome
- Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state
- (2017) Philipp Schommers et al. Molecular Metabolism
- Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
- (2017) Olga Gruzdeva et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia
- (2016) Andrew W. Dake et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Managing dyslipidaemia in type 2 diabetes mellitus
- (2016) Auryan Szalat et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes
- (2016) Zhaoli Ling et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of hepatic energy metabolism by the nuclear receptor PXR
- (2016) Jukka Hakkola et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase
- (2016) Hannah R. Bridges et al. BMC BIOLOGY
- Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction
- (2016) Martin Bødtker Mortensen et al. Cardiovascular Diabetology
- Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes
- (2016) Peter Godsk Jørgensen et al. Cardiovascular Diabetology
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic β cells
- (2016) Jing Wang et al. CELLULAR SIGNALLING
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus
- (2016) Cecilia C. Low Wang et al. CIRCULATION
- Gut microbiome and lipid metabolism
- (2016) Zheng Wang et al. CURRENT OPINION IN LIPIDOLOGY
- Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
- (2016) Thomas A. Lutz et al. CURRENT OPINION IN LIPIDOLOGY
- Diabetic dyslipidaemia
- (2016) Handrean Soran et al. CURRENT OPINION IN LIPIDOLOGY
- [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency
- (2016) Jonas B. Jensen et al. DIABETES
- Metformin Is Associated With Higher Relative Abundance of Mucin-DegradingAkkermansia muciniphilaand Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
- (2016) Jacobo de la Cuesta-Zuluaga et al. DIABETES CARE
- Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
- (2016) David Preiss et al. DIABETES OBESITY & METABOLISM
- Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes
- (2016) Hui Fan et al. Diabetes Technology & Therapeutics
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response
- (2016) Annalisa Natalicchio et al. ENDOCRINOLOGY
- Atorvastatin Plus Metformin Confer Additive Benefits on Subjects with Dyslipidemia and Overweight/Obese via Reducing ROCK2 Concentration
- (2016) Z. Hao et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Will delayed release metformin provide better management of diabetes type 2?
- (2016) André J. Scheen EXPERT OPINION ON PHARMACOTHERAPY
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses
- (2016) Ulrich Rohde et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses
- (2016) L. C. Gormsen et al. JOURNAL OF NUCLEAR MEDICINE
- Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis
- (2016) William R. Proctor et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
- (2016) Fei Luo et al. Lipids in Health and Disease
- Atorvastatin inhibits insulin synthesis by inhibiting the Ras/Raf/ERK/CREB pathway in INS-1 cells
- (2016) Hongxi Sun et al. MEDICINE
- Pharmacometabolomic signature links simvastatin therapy and insulin resistance
- (2016) Mona Elbadawi-Sidhu et al. Metabolomics
- Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery
- (2016) Kaixin Zhou et al. Nature Reviews Endocrinology
- Effect of metformin on global gene expression in liver of KKAy mice
- (2016) Zhi-Qin Liu et al. Pharmacological Reports
- Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System
- (2016) Ingmar Lundquist et al. PLoS One
- Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells
- (2016) Melissa F. Brereton et al. Nature Communications
- Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation
- (2016) Tien-Jyun Chang et al. Scientific Reports
- Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes
- (2016) Adam R. Konopka et al. Cell Reports
- Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
- (2016) Olga Gruzdeva et al. Frontiers in Pharmacology
- Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures
- (2016) Valentina Scattolini et al. Diabetes Therapy
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures
- (2016) Valentina Scattolini et al. Diabetes Therapy
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- The Enigma of Glucose and Lipid Metabolism
- (2016) Neha J. Pagidipati et al. JAMA Cardiology
- The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin
- (2016) Zahra Kashi et al. PLoS One
- New Insights into the Regulation of Chylomicron Production
- (2015) Satya Dash et al. Annual Review of Nutrition
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome
- (2015) Marcello Arca ATHEROSCLEROSIS SUPPLEMENTS
- Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity
- (2015) Chao Zhang et al. Cardiovascular Diabetology
- Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition
- (2015) Tom J.J. Schirris et al. Cell Metabolism
- Metformin Action: Concentrations Matter
- (2015) Ling He et al. Cell Metabolism
- Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial
- (2015) Kumiko Tanaka et al. CLINICAL DRUG INVESTIGATION
- Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism
- (2015) U Anyanwagu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism
- (2015) Changting Xiao et al. DIABETES
- Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858–1867
- (2015) David P. Sonne et al. DIABETES CARE
- Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
- (2015) Tao Xu et al. DIABETES CARE
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
- (2015) Henna Cederberg et al. DIABETOLOGIA
- Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin
- (2015) Ju-Hee Oh et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
- (2015) Ele Ferrannini et al. EUROPEAN HEART JOURNAL
- Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
- (2015) Maria Carlota Dao et al. GUT
- Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes
- (2015) Tushar P. Patel et al. HEART FAILURE REVIEWS
- AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms
- (2015) Yu-Lu Dai et al. International Journal of Biological Sciences
- Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro
- (2015) Yun-Xi Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Protonation–deprotonation and structural dynamics of antidiabetic drug metformin
- (2015) Belén Hernández et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance
- (2015) Carolina Gutierrez-Repiso et al. LABORATORY INVESTIGATION
- Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
- (2015) Mustafa Kinaan et al. MEDICAL PRINCIPLES AND PRACTICE
- Type 2 Diabetes Mellitus, Metabolic Syndrome, and Mixed Dyslipidemia: How Similar, How Different, and How to Treat?
- (2015) Julian Halcox et al. Metabolic Syndrome and Related Disorders
- Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)
- (2015) Xiaomin Liang et al. MOLECULAR PHARMACEUTICS
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats
- (2015) Frank A Duca et al. NATURE MEDICINE
- Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
- (2015) Darleen A. Sandoval et al. PHYSIOLOGICAL REVIEWS
- Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
- (2015) Mohamed-Sami Trabelsi et al. Nature Communications
- Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2)
- (2015) Andre Madsen et al. Scientific Reports
- Statin-activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis
- (2015) Saki Gotoh et al. Scientific Reports
- An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials
- (2015) J. Sun et al. BMJ Open
- A gut–brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic health
- (2015) Maud Soty et al. Molecular Metabolism
- Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
- (2015) Klaus G. Parhofer Diabetes & Metabolism Journal
- Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells
- (2015) Nagendra Yaluri et al. PLoS One
- Haemostatic Effects of Metformin in Simvastatin-Treated Volunteers with Impaired Fasting Glucose
- (2014) Robert Krysiak et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?
- (2014) Joseph A. Baur et al. Cell Metabolism
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
- (2014) Tanja Dujic et al. DIABETES
- The Oral Minimal Model Method
- (2014) C. Cobelli et al. DIABETES
- Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study
- (2014) Giovanni Corrao et al. DIABETES CARE
- Intestinal glucose metabolism revisited
- (2014) Gilles Mithieux et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- AMPK in the Small Intestine in Normal and Pathophysiological Conditions
- (2014) Elodie Harmel et al. ENDOCRINOLOGY
- Statin therapy and related risk of new-onset type 2 diabetes mellitus
- (2014) Massimiliano Ruscica et al. European Journal of Internal Medicine
- The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial
- (2014) R. Neil A. Black et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades
- (2014) Alan F. Hofmann et al. JOURNAL OF LIPID RESEARCH
- Diabetic dyslipidemia
- (2014) Liya Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
- (2014) Rachel J. Perry et al. NATURE
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults
- (2014) Takehiro Sugiyama et al. JAMA Internal Medicine
- Lipids and lipid management in diabetes
- (2013) Mamta Jaiswal et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin inhibits macrophage cholesterol biosynthesis rate: Possible role for metformin-induced oxidative stress
- (2013) Marie Koren-Gluzer et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Diabetic Dyslipidemia: From Evolving Pathophysiological Insight to Emerging Therapeutic Targets
- (2013) Dominic S. Ng Canadian Journal of Diabetes
- Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations
- (2013) Kirti Kandhwal et al. CLINICAL DRUG INVESTIGATION
- Restoring Insulin Secretion (RISE): Design of Studies of β-Cell Preservation in Prediabetes and Early Type 2 Diabetes Across the Life Span
- (2013) DIABETES CARE
- Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
- (2013) Joe M. Chehade et al. DRUGS
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
- (2013) Francesco Paneni et al. EUROPEAN HEART JOURNAL
- AMPK, insulin resistance, and the metabolic syndrome
- (2013) Neil B. Ruderman et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling
- (2013) Mi-Hyun Kim et al. JOURNAL OF ENDOCRINOLOGY
- Genetic Variants of the Fatty Acid Desaturase Gene Cluster Are Associated with Plasma LDL Cholesterol Levels in Japanese Males
- (2013) Yasuko SONE et al. JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
- Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose
- (2012) Robert Krysiak et al. ATHEROSCLEROSIS
- Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis
- (2012) Marcello Arca et al. Current Vascular Pharmacology
- Pancreatic β-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes
- (2012) S. J. Muhammed et al. DIABETES OBESITY & METABOLISM
- Metformin Stimulates FGF21 Expression in Primary Hepatocytes
- (2012) Eva B. Nygaard et al. Experimental Diabetes Research
- Overview of metformin: special focus on metformin extended release
- (2012) Shamsa Ali et al. EXPERT OPINION ON PHARMACOTHERAPY
- AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases
- (2012) Rai Ajit K. Srivastava et al. JOURNAL OF LIPID RESEARCH
- The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose
- (2012) Robert Krysiak et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Increased neuronal nitric oxide synthase dimerisation is involved in rat and human pancreatic beta cell hyperactivity in obesity
- (2011) K. Mezghenna et al. DIABETOLOGIA
- Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study
- (2010) Dimitris Tousoulis et al. CLINICAL THERAPEUTICS
- Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic -Cell Dysfunction
- (2010) M. Vergeer et al. DIABETES CARE
- Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
- (2010) Arpita Chakraborty et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia
- (2010) P. Matafome et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Electrodeless, accurate pH determination in highly basic media using a new set of 1H NMR pH indicators
- (2010) Gábor Orgován et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
- (2009) B. Viollet et al. Acta Physiologica
- Regulation Mechanisms and Signaling Pathways of Autophagy
- (2009) Congcong He et al. Annual Review of Genetics
- Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?
- (2009) E. Bosi DIABETES OBESITY & METABOLISM
- Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus
- (2009) Dimitris Tousoulis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of High-Dose Simvastatin Therapy on Glucose Metabolism and Ectopic Lipid Deposition in Nonobese Type 2 Diabetic Patients
- (2008) J. Szendroedi et al. DIABETES CARE
- Metformin and the intestine
- (2008) C. J. Bailey et al. DIABETOLOGIA
- Effects of Atorvastatin and Pravastatin on Signal Transduction Related to Glucose Uptake in 3T3L1 Adipocytes
- (2008) Akira Takaguri et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started